EditorialEditorial
DNA methylation profiles in cancer: functions, therapy, and beyond
Jinrong Zhu, Yongjie Yang, Li Li, Jiuren Tang and Rongxin Zhang
Cancer Biology & Medicine February 2024, 21 (2) 111-116; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0403
Jinrong Zhu
Laboratory of Immunology and Inflammation, School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China
Yongjie Yang
Laboratory of Immunology and Inflammation, School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China
Li Li
Laboratory of Immunology and Inflammation, School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China
Jiuren Tang
Laboratory of Immunology and Inflammation, School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China
Rongxin Zhang
Laboratory of Immunology and Inflammation, School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China
References
- 1.↵
- Cheng Y,
- He C,
- Wang M,
- Ma X,
- Mo F,
- Yang S, et al.
- 2.↵
- 3.↵
- Hanahan D,
- Weinberg RA.
- 4.↵
- Chen JJ,
- Wang AQ,
- Chen QQ.
- 5.↵
- Wang S,
- Fu J,
- Fang X.
- 6.↵
- Liang WW,
- Lu RJ,
- Jayasinghe RG,
- Foltz SM,
- Porta-Pardo E,
- Geffen Y, et al.
- 7.↵
- Zhao A,
- Zhou H,
- Yang J,
- Li M,
- Niu T.
- 8.↵
- Zagorac S,
- Alcala S,
- Fernandez BG,
- Bou KT,
- Schoenhals M,
- Gonzalez-Neira A, et al.
- 9.↵
- 10.↵
- Liu R,
- Zhao E,
- Yu H,
- Yuan C,
- Abbas MN,
- Cui H.
- 11.↵
- Kiyotani K,
- Toyoshima Y,
- Nakamura Y.
- 12.↵
- 13.↵
- Guo H,
- Vuille JA,
- Wittner BS,
- Lachtara EM,
- Hou Y,
- Lin M, et al.
- 14.↵
- Belk JA,
- Daniel B,
- Satpathy AT.
- 15.↵
- Lai SC,
- Su YT,
- Chi CC,
- Kuo YC,
- Lee KF,
- Wu YC, et al.
- 16.↵
- Stewart ML,
- Tamayo P,
- Wilson AJ,
- Wang S,
- Chang YM,
- Kim JW, et al.
- 17.↵
- Wang N,
- Ma T,
- Yu B.
- 18.↵
- Zhou S,
- Ou H,
- Wu Y,
- Qi D,
- Pei X,
- Yu X, et al.
- 19.↵
- Li Y,
- Porta-Pardo E,
- Tokheim C,
- Bailey MH,
- Yaron TM,
- Stathias V, et al.
- 20.↵
- Geffen Y,
- Anand S,
- Akiyama Y,
- Yaron TM,
- Song Y,
- Johnson JL, et al.
In this issue
DNA methylation profiles in cancer: functions, therapy, and beyond
Jinrong Zhu, Yongjie Yang, Li Li, Jiuren Tang, Rongxin Zhang
Cancer Biology & Medicine Feb 2024, 21 (2) 111-116; DOI: 10.20892/j.issn.2095-3941.2023.0403
Jump to section
- Article
- DNA methylation in cancer
- DNA methylation as a cancer biomarker
- Integrative multi-omic cancer profiling has revealed abnormal DNA methylation patterns and unique epigenetic characteristics in seven tumor types
- DNMT overexpression frequently contributes to the progression of hematologic malignancies
- Overexpression of DNMTs increases the potential for solid tumor formation
- DNMT deficiency induces the CSC phenotype and enhances the epithelial-mesenchymal transition (EMT) in solid tumors
- DNA methylation inhibition is used for targeted therapy in preclinical cancer treatments
- Inhibition of DNA methylation enhances intrinsic immune responses and immune cell functions during tumor progression
- Conclusions
- Author contributions
- Conflict of interest statement
- References
- Figures & Data
- References
- Info & Metrics
Related Articles
- No related articles found.
Cited By...
- No citing articles found.